T. Rowe Price Associates’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13B | Sell |
|
|||||
|
2025
Q1 | $986M | Buy |
|
|||||
|
2024
Q4 | $877M | Buy |
|
|||||
|
2024
Q3 | $918M | Buy |
|
|||||
|
2024
Q2 | $815M | Buy |
|
|||||
|
2024
Q1 | $292M | Buy |
|
|||||
|
2023
Q4 | $334M | Buy |
|
|||||
|
2023
Q3 | $263M | Buy |
|
|||||
|
2023
Q2 | $215M | Buy |
|
|||||
|
2023
Q1 | $170M | Buy |
|
|||||
|
2022
Q4 | $199M | Buy |
|
|||||
|
2022
Q3 | $206M | Sell |
|
|||||
|
2022
Q2 | $320M | Buy |
|
|||||
|
2022
Q1 | $373M | Buy |
|
|||||
|
2021
Q4 | $417M | Buy |
|
|||||
|
2021
Q3 | $406M | Buy |
|
|||||
|
2021
Q2 | $409M | Buy |
|
|||||
|
2021
Q1 | $385M | Buy |
|
|||||
|
2020
Q4 | $321M | Buy |
|
|||||
|
2020
Q3 | $305M | Sell |
|
|||||
|
2020
Q2 | $263M | Buy |
|
|||||
|
2020
Q1 | $112M | Buy |
|
|||||
|
2019
Q4 | $156M | Sell |
|
|||||
|
2019
Q3 | $120M | Sell |
|
|||||
|
2019
Q2 | $181M | Sell |
|
|||||
|
2019
Q1 | $229M | Sell |
|
|||||
|
2018
Q4 | $114M | Sell |
|
|||||
|
2018
Q3 | $212M | Sell |
|
|||||
|
2018
Q2 | $296M | Sell |
|
|||||
|
2018
Q1 | $283M | Sell |
|
|||||
|
2017
Q4 | $406M | Buy |
|
|||||
|
2017
Q3 | $401M | Buy |
|
|||||
|
2017
Q2 | $177M | Sell |
|
|||||
|
2017
Q1 | $189M | Buy |
|
|||||
|
2016
Q4 | $139M | Buy |
|
|||||
|
2016
Q3 | $146M | Buy |
|
|||||
|
2016
Q2 | $98.7M | Buy |
|
|||||
|
2016
Q1 | $122M | Buy |
|
|||||
|
2015
Q4 | $168M | Buy |
|
|||||
|
2015
Q3 | $168M | Buy |
|
|||||
|
2015
Q2 | $211M | Buy |
|
|||||
|
2015
Q1 | $174M | Buy |
|
|||||
|
2014
Q4 | $6.66M | Buy |
|
|||||
|
2014
Q3 | $5.23M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.33M | Buy |
|